Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis

Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Hubei Province, China in December 2019. At present, COVID-19 has emerged as a global pandemic. The clinical features of this disease are not fully understood, especially the interaction of COVID-19 and preexisting comorbidities and how...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jian Zhou, Dixuan Jiang, Wanchun Wang, Kang Huang, Fang Zheng, Yuanlin Xie, Zhiguo Zhou, Jingjing Sun
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 cirrhosis SARS-CoV-2 treatment cured patient Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/68ec264152dd4c52bfeacd6cf7ff920a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:68ec264152dd4c52bfeacd6cf7ff920a
record_format	dspace
spelling	oai:doaj.org-article:68ec264152dd4c52bfeacd6cf7ff920a2021-12-01T07:38:14ZCase Report: Clinical Features of a COVID-19 Patient With Cirrhosis2296-858X10.3389/fmed.2021.678227https://doaj.org/article/68ec264152dd4c52bfeacd6cf7ff920a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.678227/fullhttps://doaj.org/toc/2296-858XCoronavirus disease 2019 (COVID-19) was first reported in Wuhan, Hubei Province, China in December 2019. At present, COVID-19 has emerged as a global pandemic. The clinical features of this disease are not fully understood, especially the interaction of COVID-19 and preexisting comorbidities and how these together further impair the immune system. In this case study, we report a COVID-19 patient with cirrhosis. A 73-year-old woman with cirrhosis reported a fever and cough on February 6, 2020. CT of the chest indicated an infection in her bilateral lungs. She tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The woman was treated with lopinavir and ritonavir tablets and interferon alpha-2b injection, but there was no obvious effect. Although this patient was basically asymptomatic after 2 days in the hospital, the inflammation of the bilateral lungs was slow to subside as shown in CT of the chest. In addition, the white blood cell count (WBC), absolute neutrophil count, and absolute lymphocyte count remained decreased and the result of real-time reverse transcription polymerase chain reaction (PCR) (rRT-PCR) assay was still positive for SARS-CoV-2 on hospital day 28. After infusion of plasma from a recovered COVID-19 patient four times, the patient tested negative for SARS-CoV-2. She was discharged on March 13, 2020. This patient tested negative for SARS-CoV-2 after infusion of plasma from a recovered COVID-19 patient four times. Cirrhosis could impair the homeostatic role of the liver in the systemic immune response, which may affect the removal of SARS-CoV-2. This could lead to a diminished therapeutic effect of COVID-19. Thus, clinicians should pay more attention to COVID-19 patients with cirrhosis.Jian ZhouDixuan JiangWanchun WangKang HuangFang ZhengYuanlin XieZhiguo ZhouJingjing SunFrontiers Media S.A.articleCOVID-19cirrhosisSARS-CoV-2treatmentcured patientMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 cirrhosis SARS-CoV-2 treatment cured patient Medicine (General) R5-920
spellingShingle	COVID-19 cirrhosis SARS-CoV-2 treatment cured patient Medicine (General) R5-920 Jian Zhou Dixuan Jiang Wanchun Wang Kang Huang Fang Zheng Yuanlin Xie Zhiguo Zhou Jingjing Sun Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
description	Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Hubei Province, China in December 2019. At present, COVID-19 has emerged as a global pandemic. The clinical features of this disease are not fully understood, especially the interaction of COVID-19 and preexisting comorbidities and how these together further impair the immune system. In this case study, we report a COVID-19 patient with cirrhosis. A 73-year-old woman with cirrhosis reported a fever and cough on February 6, 2020. CT of the chest indicated an infection in her bilateral lungs. She tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The woman was treated with lopinavir and ritonavir tablets and interferon alpha-2b injection, but there was no obvious effect. Although this patient was basically asymptomatic after 2 days in the hospital, the inflammation of the bilateral lungs was slow to subside as shown in CT of the chest. In addition, the white blood cell count (WBC), absolute neutrophil count, and absolute lymphocyte count remained decreased and the result of real-time reverse transcription polymerase chain reaction (PCR) (rRT-PCR) assay was still positive for SARS-CoV-2 on hospital day 28. After infusion of plasma from a recovered COVID-19 patient four times, the patient tested negative for SARS-CoV-2. She was discharged on March 13, 2020. This patient tested negative for SARS-CoV-2 after infusion of plasma from a recovered COVID-19 patient four times. Cirrhosis could impair the homeostatic role of the liver in the systemic immune response, which may affect the removal of SARS-CoV-2. This could lead to a diminished therapeutic effect of COVID-19. Thus, clinicians should pay more attention to COVID-19 patients with cirrhosis.
format	article
author	Jian Zhou Dixuan Jiang Wanchun Wang Kang Huang Fang Zheng Yuanlin Xie Zhiguo Zhou Jingjing Sun
author_facet	Jian Zhou Dixuan Jiang Wanchun Wang Kang Huang Fang Zheng Yuanlin Xie Zhiguo Zhou Jingjing Sun
author_sort	Jian Zhou
title	Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
title_short	Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
title_full	Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
title_fullStr	Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
title_full_unstemmed	Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis
title_sort	case report: clinical features of a covid-19 patient with cirrhosis
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/68ec264152dd4c52bfeacd6cf7ff920a
work_keys_str_mv	AT jianzhou casereportclinicalfeaturesofacovid19patientwithcirrhosis AT dixuanjiang casereportclinicalfeaturesofacovid19patientwithcirrhosis AT wanchunwang casereportclinicalfeaturesofacovid19patientwithcirrhosis AT kanghuang casereportclinicalfeaturesofacovid19patientwithcirrhosis AT fangzheng casereportclinicalfeaturesofacovid19patientwithcirrhosis AT yuanlinxie casereportclinicalfeaturesofacovid19patientwithcirrhosis AT zhiguozhou casereportclinicalfeaturesofacovid19patientwithcirrhosis AT jingjingsun casereportclinicalfeaturesofacovid19patientwithcirrhosis
_version_	1718405417015443456

Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis

Ejemplares similares